Evaluation of the Efficacy and Safety of Botulinum Toxin Type A to Induce Temporary Ptosis in Dogs

Fonte: Maura Krahembuhl Wanderley Bittencourt, Jose Paulo Cabral de Vasconcellos, Matheus Domingues Bittencourt, Rodolfo Malago,and Marianna Bacellar

An example of botulinum toxin type A injection point.
   An example of botulinum toxin type A injection point.

Purpose: To verify the safety and efficacy of botulinum toxin type A (BoNT/A) to promote protective ptosis in dogs. Methods: In this prospective interventional study, a total of 10 dogs underwent transcutaneous anterior chemodenervation of levator palpebral superioris with 15U of BoNT/A. The systemic changes, ocular mobility, visual function, intraocular pressure (IOP), tear production, and the onset, degree, and duration of ptosis were evaluated on a daily basis during the first 7 days and on days 14, 21, and 28 after application. Results: The onset of the clinical effect was observed between 2 and 3 days after application of the toxin; the time taken for maximum ptosis to develop varied from 4 to 7 days (mean 5 days) and the average duration of the toxin effect was 21 days. The mean percentage reduction in palpebral fissure height was 42,859% (SD – 35,714%– 59,821%). There was not a statistically significant difference in IOP before and after the BoNT/A application (P = 0.974), or lacrimal production evaluation (P = 0.276). There was no change in ocular mobility and no other adverse effect was observed in association with the administration of the study drug. Conclusion: The application of BoNT/A into the levator palpebral superioris muscle in dogs was effective and safe to promote protective ptosis with a temporary covering of the cornea.


Visualize e/ou imprima o artigo na integra em PDF Clicando Aqui.



© 2016 Vetweb. All rights reserved | Design by VoxxDesign.com | Administração